title: The role of the hinge region of the luteinizing hormone receptor in hormone interaction and signal generation.
abstract: Luteinizing hormone receptor, a G protein-coupled receptor, consists of two halves, the N-terminal extracellular hormone binding domain (exodomain) and the C-terminal membrane-associated, signal-generating domain (endodomain). The exodomain has seven to nine Leu-rich repeats, which are generally thought to form a 1/3 donut-like structure and interact with human choriogonadotropin (hCG). The resulting hCG-exodomain complex adjusts the structure and its association with the endodomain, which results in signal generation in the endodomain. It is unclear whether the rigid 1/3 donut structure could provide the agility and versatility of this dynamic action. In addition, there is no clue as to where the endodomain contact point (the signal modulator) in the exodomain is. To address these issues, the exodomain was examined by Ala scan and multiple substitutions, while receptor peptides were used for photoaffinity labeling and affinity cross-linking. Our results show that the C-flanking sequence (hinge region), Thr(250)-Gln(268), of the Leu-rich repeats (LRRs) specifically interacts with hCG, preferentially hCGalpha. This interaction is inhibited by exoloop 2 of the endodomain but not by exoloops 1 and 3, suggesting an intimate relationship between Thr(250)-Gln(268), exoloop 2, and hCG. Taken together, our observations in this article suggest a new paradigm that the LRRs contact the front of hCG, while both flanking regions of the LRRs interact with the sides of hCG. This would trap hCG in the 1/3 donut structure of the LRRs and enhance the binding affinity. In addition, mutations of conserved Ser(255) in the sequence can constitutively activate the receptor. This provides a clue for the signal modulator in the exodomain. In contrast, a phenyl or phenolic group is necessary at conserved Tyr(253) for targeting the receptor to the surface.
authors.affiliation: Department of Chemistry, University of Kentucky, Lexington, Kentucky 40506-0055, USA.
authors.forename: H
authors.initials: H
authors.lastname: Zeng
authors.forename: T
authors.initials: T
authors.lastname: Phang
authors.forename: Y S
authors.initials: YS
authors.lastname: Song
authors.forename: I
authors.initials: I
authors.lastname: Ji
authors.forename: T H
authors.initials: TH
authors.lastname: Ji
mesh_terms: D020816:Amino Acid Motifs; D019943:Amino Acid Substitution; D001665:Binding Sites; D002478:Cells, Cultured; D006063:Chorionic Gonadotropin / Q000378:metabolism*; D017124:Conserved Sequence; D000242:Cyclic AMP / Q000096:biosynthesis; D017353:Gene Deletion; D006801:Humans; D007457:Iodine Radioisotopes; D000090263:Leucine-Rich Repeat Proteins; D008958:Models, Molecular; D019920:Photoaffinity Labels / Q000378:metabolism*; D011487:Protein Conformation; D011506:Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D011974:Receptors, LH / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D012694:Serine / Q000235:genetics; D014443:Tyrosine / Q000235:genetics
chemical_list: D006063:Chorionic Gonadotropin; D007457:Iodine Radioisotopes; D000090263:Leucine-Rich Repeat Proteins; D019920:Photoaffinity Labels; D011506:Proteins; D011974:Receptors, LH; D014443:Tyrosine; D012694:Serine; D000242:Cyclic AMP